Early Detection of Alzheimer’s Disease Using Generative Models: A Review of GANs and Diffusion Models in Medical Imaging

Alzheimer’s disease (AD) is a progressive, non-curable neurodegenerative disorder that poses persistent challenges for early diagnosis due to its gradual onset and the difficulty in distinguishing pathological changes from normal aging. Neuroimaging, particularly MRI and PET, plays a key role in detection; however, limitations in data availability and the complexity of early structural biomarkers constrain traditional diagnostic approaches. This review investigates the use of generative models, specifically Generative Adversarial Networks (GANs) and Diffusion Models, as emerging tools to address these challenges. These models are capable of generating high-fidelity synthetic brain images, augmenting datasets, and enhancing machine learning performance in classification tasks. The review synthesizes findings across multiple studies, revealing that GAN-based models achieved diagnostic accuracies up to 99.70%, with image quality metrics such as SSIM reaching 0.943 and PSNR up to 33.35 dB. Diffusion Models, though relatively new, demonstrated strong performance with up to 92.3% accuracy and FID scores as low as 11.43. Integrating generative models with convolutional neural networks (CNNs) and multimodal inputs further improved diagnostic reliability. Despite these advancements, challenges remain, including high computational demands, limited interpretability, and ethical concerns regarding synthetic data. This review offers a comprehensive perspective to inform future AI-driven research in early AD detection.